Kurve Therapeutics Clinical Trials
As we advance through each clinical trial phase, we want to offer transparency and insight into our efforts. We have successfully met our endpoints in Phase IIb in 3 separate clinical trials and are currently Phase III ready. This is where you can find the latest list of clinical trials that Kurve has participated in, for which our next-generation technology was the device of choice.
|Field of Study||Conducted by|
|Alzheimer’s Disease||Johns Hopkins|
|Alzheimer’s Disease (Phase I, II and IIB)||Wake Forest|
|Alzheimer’s Disease||Shankle Neurology Clinic|
|Parkinson’s Disease||Shankle Neurology Clinic|
|Parkinson’s Disease||University of Massachusetts|
|Multi-System Atrophy||University of Massachusetts|
|Cognition in Diabetics||Harvard Medical School|
|Cognition in multiple sclerosis (MS)||Johns Hopkins|
|Traumatic Brain Injury||Department of Defense|
|PTSD||Department of Defense|
|PTSD||Mount Sinai School of Medicine|
|Neuropathic Pain||Johns Hopkins|
|Mood and Anxiety Disorders||Karolinska University (Sweden)|
|Life Extension||Leiden University (Netherlands)|
Current Clinical Trial
Past Clinical Trials
Subscribe To Stay Up to Date
Stay up-to-date on Kurve Therapeutics’ breakthrough approach to treating CNS disorders by subscribing below. Learn more about CNS disorders, disease-modifying drugs and technology, clinical trials, and case studies. Kurve’s industry experts will help keep you informed.
Clinical trial reports available upon request
If you have additional questions, please contact us.